Status:
NOT_YET_RECRUITING
Feasibility Study of AMENUCED Program in Type 2 Diabetes
Lead Sponsor:
Universidad de Sonora
Conditions:
Diabete Type 2
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Type 2 diabetes is characterized by progressive resistance to the effects of insulin, along with deficient insulin production. In Mexico, it affects 18.4% of adults and is the second leading cause of ...
Eligibility Criteria
Inclusion
- Adults aged ≥18 and ≤65 years
- Residing in Hermosillo, Sonora
- Body Mass Index (BMI) ≥25
- Prior diagnosis of Type 2 Diabetes
- Individuals who cannot read or write may be included if accompanied by someone willing to attend sessions and assist with comprehension
- Must have active medical insurance
Exclusion
- Diabetes-related complications, including:
- Advanced diabetic nephropathy
- Neuropathy
- Retinopathy
- Cardiovascular or cerebrovascular diseases
- History of severe hypoglycemia
- Significant metabolic dysregulation (HbA1c ≥10%)
- Use of insulin, sulfonylureas, or meglitinides
- Pregnancy or breastfeeding within the past 6 months
- Diagnosed psychiatric disorders
- Consumption of ≥14 alcoholic beverages per week
- Serious illnesses (e.g., cancer, liver failure, kidney disease)
- Chronic use of corticosteroids
- Plans to relocate during the study period
- Weight loss greater than 5% in the past three months
- History of bariatric surgery
- Any other medical, psychiatric, or behavioral condition that, in the investigator's judgment, may interfere with participation in the intervention
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT07186686
Start Date
September 1 2025
End Date
December 1 2025
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Promoción de Salud Nutricional (CPSN), Hermosillo, Sonora 83000
Hermosillo, Sonora, Mexico, 83000